about
mission / vision
our team
board members
executive leadership
scientists
careers
postdoctoral programs
internship programs
current job opportunities
| |
 |
Rhea N. Coler, PhD
Vice President, Preclinical Biology
Rhea Coler is the Vice President of Preclinical Biology at
IDRI. Her work focuses on the characterization of candidate
vaccines for tuberculosis, leishmaniasis, pneumococcus,
malaria and chlamydia. Uncovering the roles that innate and
adaptive immunity play during these infectious processes
are key research questions in the Coler lab. Elucidating the
mechanisms of protection against these diseases could lead
to the development of novel prophylactic and therapeutic
interventions.
Rhea currently serves on the boards of the SPHCM and
Bertschi School, and is an Affiliate Associate Professor in
the Department of Global Health at the University of
Washington. She has been the recipient of several
fellowships and grants awarded by the NIH/NIAID, the
Medical Research Council (MRC), and PATH Vaccine
Solutions. She has several patents and has co-authored
more than 20 original articles. After doing field work on
malaria control in Tanzania, she returned to Trinidad where
she worked in the Department of Parasitology and
Entomology at the Caribbean Epidemiology Center
(CAREC), funded in part by the Center for Disease Control
and the World Health Organization.
Rhea received her BSc from McGill University and her MSc
in the field of Medical Parasitology at the London School of
Hygiene and Tropical Medicine. She obtained her PhD from
the School of Public Health and Community Medicine
(SPHCM) at the University of Washington.
|
|
